VIA DERM Trademark

Trademark Overview

On Tuesday, September 15, 2020, a trademark application was filed for VIA DERM with the United States Patent and Trademark Office. The USPTO has given the VIA DERM trademark a serial number of 90181817. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2024. This trademark is owned by Vivex Biologics Group, Inc.. The VIA DERM trademark is filed in the Pharmaceutical Products category with the following description:

Biological amniotic tissue intended for subsequent implantation
via derm

General Information

Serial Number90181817
Word MarkVIA DERM
Filing DateTuesday, September 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements

Goods and ServicesBiological amniotic tissue intended for subsequent implantation
NOT AVAILABLE"DERM"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVivex Biologics Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339
Party NameVivex Biologics Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAtlanta, GA 30339

Trademark Events

Event DateEvent Description
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 18, 2020NEW APPLICATION ENTERED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Friday, January 29, 2021NON-FINAL ACTION WRITTEN
Friday, January 29, 2021NON-FINAL ACTION E-MAILED
Friday, January 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 2, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 2, 2021SOU EXTENSION 1 FILED
Tuesday, November 2, 2021SOU EXTENSION 1 GRANTED
Thursday, November 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 10, 2022SOU EXTENSION 2 FILED
Tuesday, May 10, 2022SOU EXTENSION 2 GRANTED
Thursday, May 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 14, 2022SOU EXTENSION 3 FILED
Monday, November 14, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 6, 2023SOU TEAS EXTENSION RECEIVED
Saturday, May 6, 2023SOU EXTENSION 4 FILED
Saturday, May 6, 2023SOU EXTENSION 4 GRANTED
Tuesday, May 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, November 7, 2023SOU EXTENSION 5 FILED
Tuesday, November 14, 2023SOU EXTENSION 5 GRANTED

Related Keywords

derm subsequent implantation intended tissue amniotic biological